DPP4 and asthma: In contrast to the beneficial effects of a genetically induced CD26/DPP4 deficiency in a rat model of experimental asthma (Kruschinski et al. 2005), an aggravation of the inflammatory response was found under a continuous oral pharmacological inhibition of DPP4.